A retrospective analysis of clinical and laboratory data was made of all in-vitro fertilization (IVF) patients with tubal pathology who had their first ever embryo transfer cycle between January 1st, 1992 and September 1st, 1996. The aim of the study was to determine the effect of the presence of a hydrosalpinx, whether or not visible by ultrasound, on pregnancy, multiple pregnancy and implantation rates in our patient population. The IVF success rate was also analysed by calculating cumulative ongoing pregnancy rates of the same patient group using the lifetime table approach. In the presence of an ultrasound-visible hydrosalpinx, rates of pregnancy and multiple pregnancy appeared reduced, but the differences were not significant. The rates of implantation, clinical implantation and ongoing implantation were significantly lower in the presence of an ultrasound-visible hydrosalpinx (odds ratios 0.33-0.46, C.I. 0.21-0.96). The cumulative chance of achieving an ongoing pregnancy after one or more IVF cycles was significantly reduced in the presence of an ultrasound-visible hydrosalpinx (relative hazard 0.36, C.I. 0.22-0.59). In the presence of a hydrosalpinx not visible by ultrasound the IVF outcome was not reduced. This retrospective study confirms that patients with hydrosalpinges have an impaired IVF outcome. Unique to this study and previously unobserved is the finding that there is a subgroup of patients with hydrosalpinges, those with ultrasound-visible hydrosalpinges, which is exclusively responsible for this impaired outcome.
Introduction
It has been suggested that there is a subgroup of patients with tubal infertility, those with hydrosalpinges, who have a lower chance of achieving a pregnancy by means of in-vitro fertilization (IVF) (Andersen et al., 1994; Kassabji et al., 1994; Strandell et al., 1994; Karube et al., 1995; Meyer and Beyler, 1995; Pados et al., 1995; Vandromme et al., 1995; Agnani 1696 © European Society for Human Reproduction and Embryology et al., 1996; Akman et al., 1996; Fleming and Hull, 1996; Katz et al., 1996) .
Previous studies in this field determined the presence of a hydrosalpinx either alone on the basis of hysterosalpingographic and/or laparoscopic findings or solely by ultrasonographic findings. We had the impression that only when (or only if?) a hydrosalpinx was detectable by ultrasound, it was associated with poor IVF outcome. We therefore analysed the data of our patient population with tubal infertility, using both hysterosalpingographic/laparoscopic and ultrasonographic findings side by side to determine the presence of a hydrosalpinx.
Materials and methods
Since 1992, data from all IVF cycles have been recorded in a computer database (Status F, Bureau Medische Automatisering, De Meern, The Netherlands). Using this database, we identified and included in the study all patients who underwent IVF/intracytoplasmic sperm injection (ICSI) embryo transfer cycles between January 1st, 1992 and September 1st, 1996 with a primary indication of tubal pathology. Tubal pathology was defined as any impairment of tubal function, regardless of the cause and includes for example sterilized patients, patients who failed to achieve a pregnancy after reconstructive surgery, and patients with adhesion formation due to endometriosis. In our clinic patients with tubal pathology are routinely assessed whether they are suitable candidates for reconstructive surgery before attempting IVF (Boer-Meisel et al., 1986) . During the study period hydrosalpinges not amenable to surgery were not removed during routine laparoscopy. If during reconstructive surgery only one tube was amenable to surgery the other one was removed. As hydrosalpinx is not a characteristic recorded in the database, all patient records were reviewed. Identification of those patients with hydrosalpinges was made on the basis of hysterosalpingography and/ or laparoscopy/laparotomy notes.
When a hydrosalpinx is seen during ultrasonographic monitoring of ovarian hyperstimulation, it is customary in our clinic to record it on the stimulation flow-sheet. This made it possible to subdivide patients with a hydrosalpinx, depending on whether or not the hydrosalpinx was visible by ultrasound. Thus, depending on the tubal state, patients were classified into three groups: (i) those with tubal damage but no hydrosalpinges (Tubal group No-HSX); (ii) those with hydrosalpinges not visible by ultrasound (Tubal group HSX-invis); and (iii) those with hydrosalpinges visible by ultrasound (Tubal group HSX-vis). If after salpingostomy no evaluation of tubal state had been performed, patients were considered not to have a hydrosalpinx unless one was noted during ultrasonography. In this case they were included in the hydrosalpinx group. If a hydrosalpinx were suspected by ultrasonography, but not shown by hysterosalpingography and/ or laparoscopy/laparotomy, the patient was included in the nonhydrosalpinx group (two patients with extensive adhesions due to endometriosis). No differentiation was made between patients with unilateral or bilateral hydrosalpinges, nor was the size of the hydrosalpinx classified.
The study was restricted to cycles in which a fresh embryo transfer was performed, as we wanted to study only the effect of having hydrosalpinges on implantation and pregnancy rates. As it has been suggested that less fertile patients, repeatedly returning for treatment, may be over-represented when analysing all cycles, we included only first ever embryo transfer cycles (Fleming and Hull, 1996) . As many patients undergo repeated IVF cycles, the chance of a successful outcome after several IVF cycles might be more informative than pregnancy rates per cycle. Therefore, the IVF success rate was also analysed by calculating cumulative ongoing pregnancy rates of the same patient group using the lifetime table approach (Kaplan and Meier, 1958) .
IVF treatment was undertaken using standardized treatment protocols of pituitary desensitization and ovarian hyperstimulation with gonadotrophins as described previously (Roseboom et al., 1995) . In addition, some patients were stimulated with a combination of clomiphene citrate and gonadotrophins, gonadotrophins alone, or had IVF treatment during natural unstimulated cycles. Before 1993, pituitary desensitization was achieved with a short protocol; thereafter a long protocol was preferred, reserving the short protocol for patients above 37 years of age, or patients with a previously unsatisfactory response to a long protocol. Since 1993, a maximum of two or three embryos was transferred depending on the age of the patient; before that date the maximum was four.
Hydrosalpinx was defined as the filling of the distal segment of the tube, with abnormal distension, but with no spill of the radioopaque fluid and/or methylene blue dye into the abdominal cavity due to complete closure of the fimbrial ends of the tube. It was not possible in retrospect to ensure that the hydrosalpinges detected by ultrasound fulfilled the ultrasonographic definition of a hydrosalpinx, as they were not fully described. However, in our clinic a hydrosalpinx generally has to fulfil the following criterion: an echo-free process of irregular shape located near but outside the ovary.
Pregnancy was defined as any human chorionic gonadotrophin (HCG) serum level Ͼ5 U/l on day 15 after oocyte retrieval. Clinical pregnancy was defined as a progressive rise of serum HCG level Ͼ50 U/l on day 19 after oocyte retrieval and without menstrual bleeding occurring after ending luteal support. Ongoing pregnancy was defined as a pregnancy with at least one fetus exhibiting cardiac activity 10 weeks after oocyte retrieval. Multiple pregnancy was defined as an ongoing pregnancy with more than one fetus exhibiting cardiac activity. Pregnancy rates, clinical pregnancy rates and ongoing pregnancy rates were expressed per embryo transfer cycle. Multiple pregnancy rates were expressed per ongoing pregnancy.
The implantation rate was defined as the ratio between implanted and transferred embryos. The number of implanted embryos was presumed to be one in cases of miscarriage before ultrasonography had been performed, in cases of ectopic pregnancy, and when no gestational sac was observed by ultrasound. In all other cases the number of gestational sacs seen by ultrasonography was counted, whether or not a fetal heart beat was present. Similarly, rates for individual clinical pregnancy per transferred embryo (clinical implantation rate) and individual ongoing pregnancy per transferred embryo (ongoing implantation rate) were calculated. Age was calculated on the day of oocyte retrieval.
Statistical analysis
Statistical analysis was made using BMDP 7.0 (Dixon, 1992) . Statistical comparisons between clinical and biochemical data of the tubal groups were made by Pearson χ 2 or analysis of variance (if significant, post-hoc tests between values from the different tubal 1697 groups were performed using the Tukey Studentized range method). Where appropriate, data were logarithmically transformed to adjust for non-Gaussian distribution.
Differences in multiple pregnancy rates between the tubal groups were assessed using Pearson χ 2 . To identify influential independent variables associated with successful outcome in first ever transfer cycles a multiple stepwise logistic regression analysis was performed.
Cox proportional hazards analysis was performed on the lifetime tables data.
Results

Overall clinical results
A total of 550 patients with tubal pathology underwent their first embryo transfer cycle during the study period. Of these, 364, 186, 72, 38 and 21 patients had a second to sixth embryo transfer cycle, respectively. In addition, a further 14 cycles were performed for patients who had undergone six or more transfers. At least one hydrosalpinx was detectable by ultrasound in 51% of the patients with hydrosalpinges (115 out of 124 patients).
Clinical and biochemical data of the first embryo transfer cycle are presented in Table I . Age and the percentage of patients with a disturbance of the cycle differed significantly between the Tubal groups. The post-hoc tests revealed that the mean age in Tubal group HSX-invis was lower than the mean ages of the Tubal groups No-HSX and HSX-vis and that Tubal group HSX-vis had more patients with a disturbance in the cycle than Tubal groups No-HSX and HSX-invis. All other clinical and biochemical data were not statistically different between groups.
The results of the patients' first embryo transfer cycles are presented in Table II . In summary, regardless of which outcome parameter is considered, patients with an ultrasound-visible hydrosalpinx (Tubal group HSX-vis) had a 2-to 3-fold lower success rate compared with both control patients (Tubal group No-HSX) and those with a hydrosalpinx not visible by ultrasound (Tubal group HSX-invis). Tubal group No-HSX and Tubal group HSX-invis had very similar results. Although at first glance there appears to be a large difference in multiple pregnancy rates between the Tubal groups, this did not reach statistical significance. There was no difference in early pregnancy loss between the Tubal groups.
The number and percentages of ongoing pregnancies during successive embryo transfer cycles are presented in Table III . Figure 1 shows the Kaplan-Meier curves. Regardless of embryo transfer cycle number, patients in Tubal group HSXvis performed worse than those in Tubal groups No-HSX or HSX-invis. Although a reasonable percentage of patients achieved an ongoing pregnancy after three or more embryo transfer cycles in Tubal groups No-HSX and HSX-invis, there was virtually none in Tubal group HSX-vis.
Logistic regression analysis was performed on dependent factors of pregnancy rate, clinical pregnancy rate and ongoing pregnancy rate, respectively. In none of these analyses was tubal pathology a significant prognostic factor, even after correcting for the two recurrent significant prognostic factors, namely stimulation protocol (long protocol performed better than short) and the number of embryos transferred. COP, cumulative ongoing pregnancy rate, not corrected by lifetime tables; OPR, ongoing pregnancy rate, using all cycles.
To analyse rates of implantation, clinical implantation and ongoing implantation, patient data were analysed according to the number of embryos transferred. The number of positive outcome values was represented by the number of gestational sacs (or number of fetuses with cardiac activity at 10 weeks' gestation in the case of ongoing implantation rate). Thus, if a patient had three embryos transferred, resulting in an ongoing twin pregnancy, her data were entered three times into the database, twice with a positive outcome, and once with a negative outcome. Tubal pathology was a significant prognostic factor for these three outcomes (implantation rate, clinical implantation rate and ongoing implantation rate), even when corrected for the stimulation protocol used and number of embryos transferred (Table IV) . Having an ultrasound visible hydrosalpinx was negatively correlated with all three implantation rates.
Cox proportional hazards analysis on lifetime tables
The variables referred to in Table I were assumed to be unchanged over cycles and data of the last cycle were used. However, as many patients who had more than one embryo transfer cycle received different stimulation protocols in subsequent cycles, in addition to patients receiving short, long and other protocols in the last cycle, five other groups were constructed: patients receiving only short protocols; predominantly short protocols; only long protocols; predominantly long protocols; and only other protocols or predominantly other protocols.
In the first step of the Cox proportional hazard regression analysis, the odds ratio for Tubal group HSX-vis was by far the most significant. After entering this variable, subsequent correction for other variables neither influenced its relative hazard to any major degree, nor did there appear to be a significant difference in hazard for the other two Tubal groups (see Table IV ). Thus, the cumulative chance of achieving an ongoing pregnancy after one or more IVF cycles was significantly reduced in the presence of an ultrasound-visible hydrosalpinx.
Discussion
A number of recently published retrospective studies have shown that hydrosalpinges are associated with reduced IVF Step ϭ significant factor added to the model.
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outcome (Andersen et al., 1994; Kassabji et al., 1994; Strandell et al., 1994; Karube et al., 1995; Meyer and Beyler, 1995; Pados et al., 1995; Vandromme et al., 1995; Agnani et al., 1996; Akman et al., 1996; Fleming and Hull, 1996; Katz et al., 1996) . Fleming and Hull (1996) suggested that less fertile patients, repeatedly returning for treatment, may be over-represented when analysing all cycles and thus included only first embryo transfer cycles. However, as many patients undergo repeated IVF cycles, by analysing only first cycles, information may be lost. Furthermore, the chance of a successful outcome after several IVF cycles might be more informative than pregnancy rates per cycle. Therefore, we also analysed our data by calculating cumulative ongoing pregnancy rates using the lifetime table approach. We confirmed that an ultrasoundvisible hydrosalpinx appears to reduce the chance of a pregnancy, but the differences were not significant. However, the implantation rate, clinical pregnancy rate per transferred embryo and ongoing pregnancy rate per transferred embryo were significantly lower in the presence of an ultrasound-visible hydrosalpinx. Moreover, using the lifetime table approach, the cumulative chance of an ongoing pregnancy after one or more IVF cycles was significantly reduced in the presence of an ultrasound-visible hydrosalpinx.
Other studies in this field determined the presence of a hydrosalpinx either alone on the basis of hysterosalpingographic and/or laparoscopic findings or solely by ultrasonographic findings. We used both approaches side by side to determine the presence of a hydrosalpinx. Consequently, this study shows that IVF outcome is reduced only if a hydrosalpinx is visible by ultrasound. With successive IVF treatment cycles the chance of achieving a successful outcome diminishes to virtually zero in the presence of an ultrasound visible hydrosalpinx. This is in contrast to the other two tubal pathology groups. Therefore, future and ongoing prospective trials should classify and analyse subgroups of hydrosalpinx patients according to the ultrasonographic detection of the hydrosalpinx.
It has been debated whether it is justified at present to counsel patients with hydrosalpinges regarding surgical correction before attempting IVF (Anderson et al., 1996; Puttemans and Brosens, 1996) . In our view, because all the available evidence is retrospective, or is from open studies, one should wait for the results of prospective randomized trials before advocating routine preventive salpingectomy. Perhaps, taking our findings into account, an exception could be made for patients with ultrasound-visible hydrosalpinges not amenable to reconstructive surgery and who have undergone several unsuccessful IVF attempts. The association found between the presence of ultrasound-visible hydrosalpinges and poor IVF outcome is an additional argument in favour of reconstructive surgery, when thought feasible, before attempting IVF. Criteria mentioned by Boer-Meisel et al. (1986) and De Bruyne et al. (1997) might be helpful in identifying such patients.
As in all retrospective studies, where the potential for bias is greater than in randomized prospective studies, we cannot exclude that part of the results are due to bias. In most instances, the echographists were not aware of the exact nature of the tubal pathology, as during ultrasonography only the stimulation flow sheet was available to them stating solely whether or not tubal pathology was present. In our opinion, division of the patients into groups depending on whether or not they had a hydrosalpinx is definite. Less certain is the division of the hydrosalpinx group into subgroups with hydrosalpinges either visible or not visible by ultrasound during ovarian hyperstimulation, as documentation of the presence of a hydrosalpinx was not an essential parameter for monitoring ovarian hyperstimulation. Because of the retrospective design of our study, we cannot give information about the reproducibility of the ultrasound findings. In fact, it was noted that in a few patients, a hydrosalpinx visible by ultrasound was not recorded in every cycle. It is not known whether this was because it was not present in some cycles or was due to the failure of the observer either to notice the presence of a hydrosalpinx or to document it. However, this potential bias would reduce the observed difference, as the control group may include some patients with poor prognosis. A primary concern is whether patients with an ultrasound-visible hydrosalpinx differ from the two other tubal pathology groups in ways that may influence the chance of achieving a successful outcome of IVF. Although using a multiple stepwise regression analysis and Cox proportional hazard analysis permitted adjustment for confounding factors, it is possible that other confounding factors not yet recognized occur to some extent. Support for our findings can be found in the work of Strandell et al. (1994) , who arbitrarily subdivided their hydrosalpinx group into patients with slightly and markedly distended hydrosalpinges; presumably, the latter are those more likely to be seen during ultrasonography. Compared with the control group, patients with markedly distended hydrosalpinges had a reduced IVF outcome, while only a modest (nonsignificant) reduction was seen in patients with slightly distended hydrosalpinges. Furthermore, Agnani et al. (1996) reported a worsened prognosis when a hydrosalpinx was detectable by ultrasonography, though they did not provide any data to support this.
It is not known how a hydrosalpinx impairs IVF outcome, though several mechanisms have been suggested. Sharara et al. (1996) suggested that chronic endometritis due to Chlamydia trachomatis, leading to altered endometrial receptivity, may 1700 play a role. They interpreted their data as support for this mechanism because they pretreated all of their patients with elevated chlamydial antibody titres with doxycycline and, in contrast to others, were unable to identify any statistical difference between groups with and without a hydrosalpinx in terms of implantation rate, pregnancy rate and early pregnancy loss. However, the number of patients and cycles analysed was relatively small, so that they may have had difficulty in achieving adequate statistical power to detect the observed Ͼ25% lower ongoing pregnancy rate in the hydrosalpinx group. Also, the similar rates of elevated chlamydial antibodies in both groups found by Shahara et al. and by Fleming and Hull (1996) , who did find a reduced IVF outcome in the presence of a hydrosalpinx, argues against chronic endometritis due to chlamydial infection as the cause of reduced IVF outcome.
Uterine fluid volume has been found to be increased in the midcycle, when compared with the follicular and midluteal phases, partly due to midcycle supplementation by tubal fluid (Casslén, 1986) . It has also been noted in some instances that drainage of hydrosalpinx fluid to the uterine cavity occurs (Sinha, 1959; Mansour et al., 1991; Russell et al., 1991) . Thus, it has been postulated that, due to leakage of hydrosalpinx fluid into the uterine cavity, the receptivity of the endometrium may be disturbed and/or embryotoxic components of hydrosalpinx fluid may interfere with the development of the embryo (Anderson et al., 1994; Meyer and Beyler, 1995; Mukherjee et al., 1996) . Our observation is that only when the dilated tube contains a certain amount of fluid (otherwise it would not be visualized by ultrasound) does a reduced IVF outcome occur, which is in line with the hypothesis that a reduction in IVF outcome is due to leakage of hydrosalpinx fluid into the uterine cavity. Thus, the amount of hydrosalpinx fluid, rather than local inflammatory conditions, seems to cause reduced IVF outcome.
In summary, our retrospective study confirms that patients with hydrosalpinges have an impaired IVF outcome. Unique to this study and previously unobserved is the finding that there is a subgroup of hydrosalpinx patients, those with ultrasound-visible hydrosalpinges, which is exclusively responsible for this impaired outcome. Although studies with patients acting as their own historical control suggest that operative correction of hydrosalpinx before IVF normalizes IVF outcome (Vandromme et al., 1995; Shelton et al., 1996) , to settle finally the question whether or not the presence of a hydrosalpinx which is amenable to surgery is an unfavourable prognostic feature in IVF, we need to wait for the results of prospective randomized trials.
